Several studies have shown that epidermal growth factor (EGF) acts as a remyelinating stimulator by promoting the differentiation of oligodendrocyte precursor cells (OPCs) in myelinating oligodendrocytes (OLs), which could be favorable for its application in the treatment of demyelinating diseases [3,4,5,6]. This evidence concerns the gene EGF and demyelinating disease.